RAPT
Price
$1.15
Change
+$0.08 (+7.48%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
150.49M
57 days until earnings call
SPRO
Price
$0.74
Change
-$0.01 (-1.33%)
Updated
Mar 11, 04:54 PM (EDT)
Capitalization
40.2M
One day until earnings call
Ad is loading...

RAPT vs SPRO

Header iconRAPT vs SPRO Comparison
Open Charts RAPT vs SPROBanner chart's image
RAPT Therapeutics
Price$1.15
Change+$0.08 (+7.48%)
Volume$17.09K
Capitalization150.49M
Spero Therapeutics
Price$0.74
Change-$0.01 (-1.33%)
Volume$600
Capitalization40.2M
RAPT vs SPRO Comparison Chart
Loading...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RAPT vs. SPRO commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RAPT is a StrongBuy and SPRO is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (RAPT: $1.07 vs. SPRO: $0.74)
Brand notoriety: RAPT and SPRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RAPT: 91% vs. SPRO: 65%
Market capitalization -- RAPT: $150.49M vs. SPRO: $40.2M
RAPT [@Biotechnology] is valued at $150.49M. SPRO’s [@Biotechnology] market capitalization is $40.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RAPT’s FA Score shows that 0 FA rating(s) are green whileSPRO’s FA Score has 1 green FA rating(s).

  • RAPT’s FA Score: 0 green, 5 red.
  • SPRO’s FA Score: 1 green, 4 red.
According to our system of comparison, SPRO is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RAPT’s TA Score shows that 3 TA indicator(s) are bullish while SPRO’s TA Score has 5 bullish TA indicator(s).

  • RAPT’s TA Score: 3 bullish, 4 bearish.
  • SPRO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SPRO is a better buy in the short-term than RAPT.

Price Growth

RAPT (@Biotechnology) experienced а +1.90% price change this week, while SPRO (@Biotechnology) price change was -4.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.64%. For the same industry, the average monthly price growth was -8.11%, and the average quarterly price growth was -7.39%.

Reported Earning Dates

RAPT is expected to report earnings on May 08, 2025.

SPRO is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+0.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPT($150M) has a higher market cap than SPRO($40.2M). SPRO YTD gains are higher at: -28.417 vs. RAPT (-32.278). SPRO has higher annual earnings (EBITDA): -2.45M vs. RAPT (-113.61M). RAPT has more cash in the bank: 97.9M vs. SPRO (76.3M). SPRO has less debt than RAPT: SPRO (4.62M) vs RAPT (5.12M). SPRO has higher revenues than RAPT: SPRO (89.9M) vs RAPT (0).
RAPTSPRORAPT / SPRO
Capitalization150M40.2M373%
EBITDA-113.61M-2.45M4,643%
Gain YTD-32.278-28.417114%
P/E RatioN/A9.22-
Revenue089.9M-
Total Cash97.9M76.3M128%
Total Debt5.12M4.62M111%
FUNDAMENTALS RATINGS
SPRO: Fundamental Ratings
SPRO
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
76
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RAPTSPRO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 5 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIDRX9.11N/A
N/A
Lord Abbett International Value R2
RPBAX26.88N/A
N/A
T. Rowe Price Balanced
AFCNX17.09N/A
N/A
American Century Focused Intl Gr Inv
MCRTX44.82N/A
N/A
Morgan Stanley Insight R6
EEMGX8.19N/A
N/A
MFS Emerging Markets Equity Research R4

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been closely correlated with JBPHF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if RAPT jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
-5.31%
JBPHF - RAPT
79%
Closely correlated
N/A
AXON - RAPT
48%
Loosely correlated
-2.08%
SLGL - RAPT
46%
Loosely correlated
+3.49%
SNDX - RAPT
45%
Loosely correlated
-6.63%
TRAW - RAPT
44%
Loosely correlated
-2.83%
More